Cortical dysfunction underlies the development of the split-hand in amyotrophic lateral sclerosis

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Menon, Parvathi ^a   Kiernan, Matthew C ^b,c   Vucic, Steve ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ABDUCTOR DIGITI MINIMI; ABDUCTOR POLLICIS BREVIS; ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BRAIN CORTEX; BRAIN DYSFUNCTION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; ECTRODACTYLY; EVOKED CORTICAL RESPONSE; EVOKED MUSCLE RESPONSE; FEMALE; FIRST DORSAL INTEROSSEOUS MUSCLE; HAND MUSCLE; HUMAN; HUMAN CELL; MALE; MIDDLE AGED; MOTONEURON; NERVE CELL EXCITABILITY; NERVE FIBER; PATHOPHYSIOLOGY; HAND; MUSCLE STRENGTH; PATHOLOGY; SKELETAL MUSCLE; SYNAPTIC TRANSMISSION; TRANSCRANIAL MAGNETIC STIMULATION;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; AXONS; CEREBRAL CORTEX; EVOKED POTENTIALS, MOTOR; FEMALE; HAND; HUMANS; MALE; MIDDLE AGED; MUSCLE STRENGTH; MUSCLE, SKELETAL; SYNAPTIC TRANSMISSION; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 84899816907     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0087124     Document Type: Article

References (52)

1. Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, et al. (2011) Amyotrophic lateral sclerosis. Lancet 377: 942-955.
2. Wilbourn AJ (2000) The "split hand syndrome". Muscle Nerve 23: 138.
3. Kuwabara S, Sonoo M, Komori T, Shimizu T, Hirashima F, et al. (2008) Dissociated small hand muscle atrophy in amyotrophic lateral sclerosis: frequency, extent, and specificity. Muscle Nerve 37: 426-430. (Pubitemid 351501967)
4. Eisen A, Kuwabara S (2012) The split hand syndrome in amyotrophic lateral sclerosis. J Neurol, Neurosurg Psychiatry 83: 399-403.
5. Bae JS, Sawai S, Misawa S, Kanai K, Isose S, et al. (2009) Differences in excitability properties of FDI and ADM motor axons. Muscle Nerve 39: 350-354.
6. Menon P, Kiernan MC, Yiannikas C, Stroud J, Vucic S (2013) Split-hand index for the diagnosis of amyotrophic lateral sclerosis. Clin Neurophysiol 124: 410-416.
7. Eisen A, Kim S, Pant B (1992) Amyotrophic lateral sclerosis (ALS): a phylogenetic disease of the corticomotoneuron? Muscle Nerve 15: 219-224.
8. Prout AJ, Eisen A (1994) The cortical silent period and ALS. Muscle Nerve 17: 217-223.
9. Vucic S, Kiernan MC (2006) Novel threshold tracking techniques suggest that cortical hyperexcitability is an early feature of motor neuron disease. Brain 129: 2436-2446. (Pubitemid 44522128)
10. Vucic S, Kiernan MC (2010) Upregulation of persistent sodium conductances in familial ALS. J Neurol Neurosurg Psychiatry 81: 222-227.
11. Vucic S, Nicholson GA, Kiernan MC (2008) Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis. Brain 131: 1540-1550.
12. Vucic S, Cheah BC, Yiannikas C, Kiernan MC (2011) Cortical excitability distinguishes ALS from mimic disorders. Clin Neurophysiol 122: 1860-1866.
13. Lemon RN, Griffiths J (2005) Comparing the function of the corticospinal system in different species: organizational differences for motor specialization? Muscle Nerve 32: 261-279. (Pubitemid 41232610)
14. Abbruzzese G, Assini A, Buccolieri A, Schieppati M, Trompetto C (1999) Comparison of intracortical inhibition and facilitation in distal and proximal arm muscles in humans. J Physiol (Lond) 514: 895-903. (Pubitemid 29060333)
15. Friedman AP, Freedman D (1950) Amyotrophic lateral sclerosis. The Journal of nervous and mental disease 111: 1-18.
16. Weber M, Eisen A, Stewart H, Hirota N (2000) The split hand in ALS has a cortical basis. J Neurol Sci 180: 66-70.
17. Shibuya K, Misawa S, Nasu S, Sekiguchi Y, Mitsuma S, et al. (2013) Split hand syndrome in amyotrophic lateral sclerosis: different excitability changes in the thenar and hypothenar motor axons. J Neurol Neurosurg Psychiatry 84: 969-972.
18. Rowland LP, Shneider NA (2001) Amyotrophic lateral sclerosis. New England Journal of Medicine 344: 1688-1700. (Pubitemid 32479968)
19. de Carvalho M, Dengler R, Eisen A, England JD, Kaji R, et al. (2008) Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol 119: 497-503.
20. Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, et al. (1999) The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 169: 13-21. (Pubitemid 29502501)
21. O'Brien MD (2004) Aid to the examination of the peripheral nervous system. 4 ed. London: W.B.Saunders. pp. 1-3.
22. Fisher RJ, Nakamura Y, Bestmann S, Rothwell JC, Bostock H (2002) Two phases of intracortical inhibition revealed by transcranial magnetic threshold tracking. Exp Brain Res 143: 240-248. (Pubitemid 34212260)
23. Vucic S, Howells J, Trevillion L, Kiernan MC (2006) Assessment of cortical excitability using threshold tracking techniques. Muscle Nerve 33: 477-486.
24. Menon P, Kiernan MC, Vucic S (2013) Cortical excitability differences in hand muscles follow a split-hand pattern in healthy controls. Muscle Nerve: doi: 10.1002/mus.24072.
25. Mills KR, Murray NM (1986) Electrical stimulation over the human vertebral column: which neural elements are excited? Electroencephalogr Clin Neurophysiol 63: 582-589. (Pubitemid 16091365)
26. Kiernan MC, Burke D, Andersen KV, Bostock H (2000) Multiple measures of axonal excitability: a new approach in clinical testing. Muscle Nerve 23: 399-409. (Pubitemid 30126986)
27. Mogyoros I, Kiernan MC, Burke D (1996) Strength-duration properties of human peripheral nerve. Brain 119: 439-447. (Pubitemid 26149359)
28. Bostock H (1983) The strength-duration relationship for excitation of myelinated nerve: computed dependence on membrane parameters. J Physiol (Lond) 341: 59-74.
29. Bostock H, Cikurel K, Burke D (1998) Threshold tracking techniques in the study of human peripheral nerve. Muscle Nerve 21: 137-158. (Pubitemid 28079733)
30. Burke D, Kiernan MC, Bostock H (2001) Excitability of human axons. Clin Neurophysiol 112: 1575-1585. (Pubitemid 32763239)
31. Bostock H, Rothwell JC (1997) Latent addition in motor and sensory fibres of human peripheral nerve. J Physiol (Lond) 498: 277-294. (Pubitemid 27056895)
32. Bostock H (1995) Mechanisms of accommodation and adaptation in myelinated axons. In: Waxman SG, Kocsis JD, Stys PK, editors. The Axon. New York: Oxford Univerisy Press. pp. 311-327.
33. Bae JS, Menon P, Mioshi E, Kiernan MC, Vucic S (2013) Cortical excitability differences between flexor pollicis longus and APB. Neurosci Lett 541: 150-154.
34. Ziemann U (2004) TMS and drugs. Clin Neurophysiol 115: 1717-1729.
35. Vucic S, Lin CS-Y, Cheah BC, Murray J, Menon P, et al. (2013) Riluzole exerts central and peripheral modulating effects in amyotrophic lateral sclerosis. Brain 136: 1361-1370.
36. Nihei K, McKee AC, Kowall NW (1993) Patterns of neuronal degeneration in the motor cortex of amyotrophic lateral sclerosis patients. Acta Neuropathologica 86: 55-64. (Pubitemid 23249074)
37. Vucic S, Ziemann U, Eisen A, Hallett M, Kiernan MC (2013) Transcranial magnetic stimulation and amyotrophic lateral sclerosis: pathophysiological insights. J Neurol Neurosurg Psychiatry 84: 1161-1170.
38. Chen R, Cros D, Curra A, Di Lazzaro V, Lefaucheur JP, et al. (2008) The clinical diagnostic utility of transcranial magnetic stimulation: report of an IFCN committee. Clin Neurophysiol 119: 504-532.
39. Komissarow L, Rollnik JD, Bogdanova D, Krampfl K, Khabirov FA, et al. (2004) Triple stimulation technique (TST) in amyotrophic lateral sclerosis.[see comment]. Clinical Neurophysiology 115: 356-360. (Pubitemid 38117256)
40. Cantello R, Gianelli M, Civardi C, Mutani R (1992) Magnetic brain stimulation: the silent period after the motor evoked potential. Neurology 42: 1951-1959.
41. Chen R, Lozano AM, Ashby P (1999) Mechanism of the silent period following transcranial magnetic stimulation. Evidence from epidural recordings. Exp Brain Res 128: 539-542. (Pubitemid 29469179)
42. Inghilleri M, Berardelli A, Cruccu G, Manfredi M (1993) Silent period evoked by transcranial stimulation of the human cortex and cervicomedullary junction. J Physiol (Lond) 466: 521-534. (Pubitemid 23225241)
43. Siebner HR, Dressnandt J, Auer C, Conrad B (1998) Continuous intrathecal baclofen infusions induced a marked increase of the transcranially evoked silent period in a patient with generalized dystonia. Muscle Nerve 21: 1209-1212. (Pubitemid 28355572)
44. Werhahn KJ, Kunesch E, Noachtar S, Benecke R, Classen J (1999) Differential effects on motorcortical inhibition induced by blockade of GABA uptake in humans. J Physiol (Lond) 517: 591-597. (Pubitemid 29296371)
45. Stetkarova I, Kofler M (2012) Differential effects of cortical and spinal inhibitory circuits. Clin Neurophysiol: In press.
46. Kanai K, Kuwabara S, Misawa S, Tamura N, Ogawara K, et al. (2006) Altered axonal excitability properties in amyotrophic lateral sclerosis: impaired potassium channel function related to disease stage. Brain 129: 953-962.
47. Kuo JJ, Siddique T, Fu R, Heckman CJ (2005) Increased persistent Na(+) current and its effect on excitability in motoneurones cultured from mutant SOD1 mice. J Physiol (Lond) 563: 843-854. (Pubitemid 40425599)
48. Vucic S, Kiernan MC (2006) Axonal excitability properties in amyotrophic lateral sclerosis. Clin Neurophysiol 117: 1458-1466. (Pubitemid 43947716)
49. Browne SE, Yang L, DiMauro JP, Fuller SW, Licata SC, et al. (2006) Bioenergetic abnormalities in discrete cerebral motor pathways presage spinal cord pathology in the G93A SOD1 mouse model of ALS. Neurobiol Dis 22: 599-610. (Pubitemid 43832131)
50. Trotti D, Rolfs A, Danbolt N, Brown R, Hediger M (1999) SOD1 mutants linked to amyotrophic lateral sclerosis selectively inactivate a glial glutamate transporter. Nat Neurosci 2: 427-433. (Pubitemid 30491252)
51. Rothstein JD, Patel S, Regan MR, Haenggeli C, Huang YH, et al. (2005) Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 433: 73-77. (Pubitemid 40101145)
52. Van Damme P, Braeken D, Callewaert G, Robberecht W, Van Den Bosch L (2005) GluR2 deficiency accelerates motor neuron degeneration in a mouse model of amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 64: 605-612. (Pubitemid 40995275)